640 related articles for article (PubMed ID: 29269154)
21. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
Dedroog S; Huygens C; Van den Mooter G
Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
[TBL] [Abstract][Full Text] [Related]
22. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
Wlodarski K; Sawicki W; Kozyra A; Tajber L
Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
[TBL] [Abstract][Full Text] [Related]
23. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
Giannachi C; Allen E; Egan G; Vucen S; Crean A
Mol Pharm; 2024 Jun; 21(6):3017-3026. PubMed ID: 38758116
[TBL] [Abstract][Full Text] [Related]
24. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
Rumondor AC; Taylor LS
Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
[TBL] [Abstract][Full Text] [Related]
25. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
26. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
[TBL] [Abstract][Full Text] [Related]
27. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
28. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
Rumondor AC; Stanford LA; Taylor LS
Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
[TBL] [Abstract][Full Text] [Related]
29. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
30. Choosing Appropriate Solvents for ASD Preparation.
Luebbert C; Real D; Sadowski G
Mol Pharm; 2018 Nov; 15(11):5397-5409. PubMed ID: 30335401
[TBL] [Abstract][Full Text] [Related]
31. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
Pavliš J; Mathers A; Fulem M; Klajmon M
Mol Pharm; 2023 Aug; 20(8):3960-3974. PubMed ID: 37386723
[TBL] [Abstract][Full Text] [Related]
32. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
Konno H; Taylor LS
Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
[TBL] [Abstract][Full Text] [Related]
33. Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions.
Patel S; Kou X; Hou HH; Huang YB; Strong JC; Zhang GGZ; Sun CC
J Pharm Sci; 2017 Jan; 106(1):217-223. PubMed ID: 27769519
[TBL] [Abstract][Full Text] [Related]
34. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Eur J Pharm Biopharm; 2019 Dec; 145():98-112. PubMed ID: 31698042
[TBL] [Abstract][Full Text] [Related]
35. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
Blaabjerg LI; Bulduk B; Lindenberg E; Löbmann K; Rades T; Grohganz H
J Pharm Sci; 2019 Aug; 108(8):2561-2569. PubMed ID: 30878513
[TBL] [Abstract][Full Text] [Related]
36. Viscoelastic Behavior of Supercooled and Glassy ASDs at Humid Conditions Can Be Predicted.
Grönniger B; Danzer A; Kimpe K; Singh A; Sadowski G
Mol Pharm; 2023 May; 20(5):2568-2578. PubMed ID: 37027344
[TBL] [Abstract][Full Text] [Related]
37. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
38. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
Mathers A; Hassouna F; Klajmon M; Fulem M
Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
40. Thermodynamic phase behavior of API/polymer solid dispersions.
Prudic A; Ji Y; Sadowski G
Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
